88 related articles for article (PubMed ID: 18080406)
1. Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.
Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(6):1-3. PubMed ID: 18080406
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.
Technol Eval Cent Assess Program Exec Summ; 2011 Mar; 25(6):1-5. PubMed ID: 21638942
[No Abstract] [Full Text] [Related]
3. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Jänne PA; Johnson BE
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4416s-4420s. PubMed ID: 16857820
[TBL] [Abstract][Full Text] [Related]
4. First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
Gridelli C
Curr Opin Oncol; 2011 Mar; 23(2):131-2. PubMed ID: 21307676
[No Abstract] [Full Text] [Related]
5. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
6. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.
da Cunha Santos G; Saieg MA; Geddie W; Leighl N
Cancer Cytopathol; 2011 Apr; 119(2):80-91. PubMed ID: 21400669
[TBL] [Abstract][Full Text] [Related]
7. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
Yuan S; Yu SL; Chen HY; Hsu YC; Su KY; Chen HW; Chen CY; Yu CJ; Shih JY; Chang YL; Cheng CL; Hsu CP; Hsia JY; Lin CY; Wu G; Liu CH; Wang CD; Yang KC; Chen YW; Lai YL; Hsu CC; Lin TC; Yang TY; Chen KC; Hsu KH; Chen JJ; Chang GC; Li KC; Yang PC
J Clin Oncol; 2011 Sep; 29(25):3435-42. PubMed ID: 21810691
[TBL] [Abstract][Full Text] [Related]
8. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
John T; Liu G; Tsao MS
Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292
[TBL] [Abstract][Full Text] [Related]
9. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
[TBL] [Abstract][Full Text] [Related]
10. Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitors.
Wong KK
Lung Cancer; 2008 Jun; 60 Suppl 2():S10-8. PubMed ID: 18513579
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Murray S; Timotheadou E; Linardou H; Vrettou AV; Kostopoulos I; Skrickova J; Papakostantinou C; Christodoulou C; Pectasides D; Samantas E; Papakostas P; Skarlos DV; Kosmidis P; Fountzilas G
Lung Cancer; 2006 May; 52(2):225-33. PubMed ID: 16567021
[TBL] [Abstract][Full Text] [Related]
12. First case of A859T epidermal growth factor receptor mutation responding to erlotinib.
Le Maignan L; Mirebeau-Prunier D; Vervueren L; Jeanfaivre T; Urban T; Hureaux J
J Thorac Oncol; 2011 Mar; 6(3):639-40. PubMed ID: 21317745
[No Abstract] [Full Text] [Related]
13. Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making.
Gandara DR; Lara PN; Mack P; Scagliotti G
Clin Lung Cancer; 2009 May; 10(3):148-50. PubMed ID: 19443333
[No Abstract] [Full Text] [Related]
14. Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.
van Noesel J; van der Ven WH; van Os TA; Kunst PW; Weegenaar J; Reinten RJ; Kancha RK; Duyster J; van Noesel CJ
J Clin Oncol; 2013 Apr; 31(10):e161-4. PubMed ID: 23358982
[No Abstract] [Full Text] [Related]
15. Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Stephens P; Hunter C; Bignell G; Edkins S; Davies H; Teague J; Stevens C; O'Meara S; Smith R; Parker A; Barthorpe A; Blow M; Brackenbury L; Butler A; Clarke O; Cole J; Dicks E; Dike A; Drozd A; Edwards K; Forbes S; Foster R; Gray K; Greenman C; Halliday K; Hills K; Kosmidou V; Lugg R; Menzies A; Perry J; Petty R; Raine K; Ratford L; Shepherd R; Small A; Stephens Y; Tofts C; Varian J; West S; Widaa S; Yates A; Brasseur F; Cooper CS; Flanagan AM; Knowles M; Leung SY; Louis DN; Looijenga LH; Malkowicz B; Pierotti MA; Teh B; Chenevix-Trench G; Weber BL; Yuen ST; Harris G; Goldstraw P; Nicholson AG; Futreal PA; Wooster R; Stratton MR
Nature; 2004 Sep; 431(7008):525-6. PubMed ID: 15457249
[TBL] [Abstract][Full Text] [Related]
16. [Experience on epidermal growth factor receptor gene mutation analysis in non-small cell lung cancer].
Zhang J; Gao J; Liang ZY; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):712-4. PubMed ID: 22321558
[No Abstract] [Full Text] [Related]
17. [Comparison of two different methods for EGFR gene mutation detection in non-small cell lung cancer].
Dong Z; Sun Y; Lu Y; Tang C; Xu Y; Liu Y; Zhu G; Liu X
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):116-9. PubMed ID: 24742573
[No Abstract] [Full Text] [Related]
18. Unlocking the biological clues of lung cancer.
Hanna N
J Thorac Oncol; 2008 Aug; 3(8):809-10. PubMed ID: 18670296
[No Abstract] [Full Text] [Related]
19. A sequential method of epidermal growth factor receptor mutation detection reduces false negatives: a new case with doublet mutations of L833V and H835L in China.
Zhuang Y; Xu J; Ma H; Zhu W; Guo L; Kang S; Guo F
Clin Lung Cancer; 2013 May; 14(3):295-300. PubMed ID: 23313172
[No Abstract] [Full Text] [Related]
20. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
Hung KS; Lee CN; Liu HE
J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
